At a glance
- Originator Meiji Dairies Corporation; Meiji Seika Kaisha; Nonindustrial source
- Class Antineoplastics; Benzopyrans; Carboxylic acids
- Mechanism of Action Telomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 01 Oct 1999 Preclinical development for Cancer in Japan (Unknown route)